Automated AI Framework Paves Way for Earlier Detection of Pancreatic Ductal Adenocarcinoma
An automated AI framework with an ensemble architecture based on deep learning approaches outperformed radiologists at detecting stage 0 pancreatic ductal adenocarcinoma, marking a significant advance in earlier detection for improved patient outcomes in a challenging cancer.
Ranking is based on citation frequency across our internal corpus of peer-reviewed articles.
#1
Mayo Clinic Comprehensive Cancer Center
Rochester, MN
Mayo Clinic is renowned for its cancer research and treatment, particularly in pancreatic cancer. It has a strong focus on innovative diagnostic techniques.
Key Differentiators
Oncology
#2
Hospital of the University of Pennsylvania
Philadelphia, PA
The Hospital of the University of Pennsylvania is a leader in cancer research, with significant contributions to the understanding of pancreatic cancer.
Key Differentiators
Oncology
#3
Cedars-Sinai Medical Center
Los Angeles, CA
Cedars-Sinai is known for its comprehensive cancer care and research, particularly in pancreatic cancer treatment.
Key Differentiators
Oncology
#4
Samuel Oschin Comprehensive Cancer Center
Los Angeles, CA
Part of Cedars-Sinai, this center focuses on innovative research and treatment options for pancreatic cancer.
Key Differentiators
Oncology
#5
University of Pittsburgh Medical Center
Pittsburgh, PA
The University of Pittsburgh Medical Center is recognized for its research in pancreatic cancer and collaboration with other institutions.
Key Differentiators
Oncology
ASCO AI in Oncology
is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in
ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.